Zdrowie i gospodarka · 17/12/2009
FDA Publishes Draft Guidance on Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
The FDA has released a draft guidance document outlining recommendations for nonclinical studies to support the safety of biotechnology-derived pharmaceuticals, building on the International Conference on Harmonisation's (ICH) S6 guidance published in 1997.